Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
25/05/2026
Ahmadzay ZF et al (EuroSpA Collaboration)
RMD Open
https://doi.org/10.1136/rmdopen-2025-006477
doi: 10.1136/rmdopen-2025-006477